移植后环磷酰胺对单倍体与HLA相合移植后免疫重建的影响
该研究分析了210例成人造血干细胞移植患者,比较单倍体移植后环磷酰胺(haplo-PTCy)、HLA相合移植后环磷酰胺(matched-PTCy)与HLA相合移植采用他克莫司/甲氨蝶呤(matched-CNI)三组的免疫重建。结果显示PTCy组T、B、NK及浆细胞样树突状细胞早期恢复延迟,haplo-PTCy更显著,且TCR多样性恢复延迟仅见于haplo-PTCy。
要点
- PTCy方案导致T、B、NK及pDC早期免疫重建延迟,haplo-PTCy延迟更明显。
- PTCy后延迟主要涉及初始CD4、CD8 T细胞及初始B细胞亚群。
- haplo-PTCy后TCR多样性恢复延迟且CD8克隆性持续升高,matched-PTCy则无此现象。
核心结论
- PTCy用于GVHD预防对免疫重建有多方面影响,但HLA相合时免疫恢复更快且TCR多样性保留更好。
研究设计与样本
- 回顾性分析210例成人造血干细胞移植患者,分为haplo-PTCy、matched-PTCy和matched-CNI三组。
- 采用流式细胞术(37种细胞表面标记)监测系列血样中T、B、NK及树突状细胞亚群。
- 对纯化CD4Treg、CD4Tcon和CD8 T细胞进行TCRVb测序评估免疫组库多样性。
主要发现
- 与matched-CNI相比,两个PTCy队列T、B、NK及浆细胞样树突状细胞早期恢复均延迟,haplo-PTCy延迟更显著。
- PTCy后延迟主要涉及初始CD4和CD8 T细胞亚群及初始B细胞群体。
- 两个PTCy组NK-T细胞和γδT细胞恢复延迟超过1年。
- haplo-PTCy后TCR多样性恢复较matched-CNI延迟,而matched-PTCy后未见延迟。
- haplo-PTCy后CD8克隆性在较晚时间点仍升高,提示该背景下免疫组库限制更持续。
临床怎么用
- 在HLA相合移植中优先考虑PTCy方案可能有利于更快免疫重建和TCR多样性保留。
- 单倍体移植后使用PTCy需警惕初始T/B细胞及NK-T、γδT细胞恢复延迟超过1年。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Post-transplant cyclophosphamide (PTCy) is increasingly used for graft-versus-host disease (GVHD) prophylaxis in both HLA-matched (matched-PTCy) and haplotype-mismatched (haplo-PTCy) hematopoietic stem cell transplantation (HCT), but the effects of PTCy on immune reconstitution in different donor settings remain incompletely characterized. We analyzed immune reconstitution in 210 adult patients undergoing haplo-PTCy, matched-PTCy, or HLA-matched HCT using tacrolimus/methotrexate (matched-CNI) for GVHD prophylaxis. Both PTCy cohorts also received tacrolimus/mycophenolate mofetil (Tac/MMF). Reconstitution of T, B, NK and dendritic-cell subsets in serial blood samples was monitored using flow cytometry and a panel of 37 cell surface markers. T cell receptor (TCRVb) sequencing was used to assess repertoire diversity in purified CD4Treg, CD4Tcon, and CD8 T cell populations. Early recovery of T, B, NK and plasmacytoid dendritic cells, was delayed in both PTCy cohorts compared with matched-CNI with more pronounced delays after haplo-PTCy. Delayed recovery after PTCy primarily involved naïve CD4 and CD8 T-cell subsets and naïve B-cell populations. Recovery of NK-T cells and γδT cells was delayed for more than 1 year in both PTCy groups. T cell receptor (TCR) sequencing revealed delayed recovery of repertoire diversity after haplo-PTCy compared to matched-CNI but not after matched-PTCy. CD8 clonality remained elevated at later time points after haplo-PTCy, suggesting more persistent repertoire restriction in this setting. Overall, these findings identify multiple effects of GVHD prophylaxis with PTCy on immune reconstitution. However, immune recovery is more rapid and T cell receptor repertoire diversity better preserved when recipient and donor are HLA-matched.
引用
- Ansuinelli M, Kim HT, Malfona F, et al. Effects of post-transplant cyclophosphamide on immune reconstitution after haploidentical and HLA-matched transplant. Blood Adv. 2026. PMID: 42950245. doi:10.1182/bloodadvances.2026019683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。